Help Wanted: What if I Can't Pay for My Cancer Care?

Article

Cost of cancer care is a growing concern of both patients and medical professionals.

Many patients are overwhelmed when facing a diagnosis of cancer. The second shock may be from the sticker price of treatment.

Even patients with insurance may be underinsured or face high out-of-pocket costs, especially if they need an oral medication as opposed to one delivered intravenously.

“Many patients are having trouble paying for their oral drugs,” says Erin Moaratty, chief of mission delivery at the Patient Advocate Foundation. A health care plan could require a co-pay for oral chemotherapy. A co-pay of 20 percent can result in an astronomical sum: $1,800 out of pocket for a $9,000-a-month pill.

Some states require health insurers to cover oral drugs at the same reimbursement rate as intravenous chemotherapy, but not every state has such a law. Unfortunately, the Patient Protection and Affordable Care Act, aka ObamaCare, does not address this issue, Moaratty says.

Pushing for Legislation

Anthony Lacey, a Maryland real estate agent, was barely able to cover the monthly $7,000 tab for his wife’s nine months of oral chemotherapy before she ultimately died of metastatic breast cancer in 2011. Because doctors could not find a similarly effective IV option, he exhausted his daughters’ college fund and now must sell his home.

As devastating as the experience was, Lacey was committed to helping others in the same boat. He helped push for a new law in his home state of Maryland that resulted in that oral chemotherapy being covered to the same extent as intravenous drugs. At least he has the knowledge that his fellow Marylanders will not face the awful dilemma that he did.

Reducing Medication Not the Answer

Medicare patients can also get caught in the “doughnut hole”—they have spent $2,800 on prescription drugs that are covered by Medicare–but it won’t pick up again until $4,550. Until then the financial burden is theirs.

A patient may decide that the only solution is to cut back on doses. Doctors would prefer a frank conversation about payment problems as they can explain that reduced doses may limit or negate the effect of therapy. In addition, physicians may have resources they can offer to help patients pay for their treatments. Pharmaceutical companies often have patient assistance programs for those who meet certain criteria, such as a fixed income and few resources. Your doctor, nurse, or a hospital navigator or social worker on staff, can help steer you to the right drug company contact, as can patient-oriented organizations such as the Cancer Support Community. Financial aid may also be available from the American Cancer Society or a cancer group that supports patients with a specific cancer type.

Ask About an Alternate Treatment

Your physician may also have treatment alternatives that may be less expensive. “If there’s no way to procure the medication without the patient purchasing it, it’s up to me to make a substitution,” says oncologist Lidia Schapira, MD, an oncologist at Massachusetts General Hospital in Boston. “Most of the time I can find a drug that is cheaper, and I do so.”

Tap into Assistance

There are several organizations, companies and institutions that offer financial help to patients for treatment costs. You can find many resources in our CURE Toolbox (under Special Interest/Financial and Drug Assistance) and “Drug Assistance Programs.”

Editor's note: CURE understands that costs of therapy may impact a patient's adherence to medication. A special supplement from CURE, which will look at barriers and improvements to adherence will be available in Spring 2013.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content